Genesis Healthcare Stock Forecast, Price & News

Genesis Healthcare (NYSE:GEN) Frequently Asked Questions

Is Genesis Healthcare a buy right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Genesis Healthcare in the last year. There are currently 1 sell rating for the stock. The consensus among Wall Street analysts is that investors should "sell" Genesis Healthcare stock.
View analyst ratings for Genesis Healthcare or view top-rated stocks.

How were Genesis Healthcare's earnings last quarter?

Genesis Healthcare, Inc. (NYSE:GEN) posted its earnings results on Monday, November, 9th. The company reported ($0.55) earnings per share (EPS) for the quarter, missing the Thomson Reuters' consensus estimate of ($0.02) by $0.53. The firm earned $938.65 million during the quarter. Genesis Healthcare had a negative trailing twelve-month return on equity of 5.06% and a negative net margin of 1.52%.
View Genesis Healthcare's earnings history.

What price target have analysts set for GEN?

1 brokers have issued 1-year target prices for Genesis Healthcare's stock. Their forecasts range from $0.57 to $0.57. On average, they expect Genesis Healthcare's stock price to reach $0.57 in the next twelve months.
View analysts' price targets for Genesis Healthcare or view top-rated stocks among Wall Street analysts.

Who are Genesis Healthcare's key executives?

Genesis Healthcare's management team includes the following people:

• Mr. Robert H. Fish, CEO & Director (Age 70, Pay $411.5k)
• Mr. Thomas DiVittorio, Exec. VP & CFO (Age 53, Pay $565k)
• Mr. Paul David Bach, COO & Exec. VP (Age 62, Pay $630k)
• Mr. Stephen Scott Young, Chief Accounting Officer & Treasurer (Age 49)
• Mr. Richard L. Castor, Chief Information Officer & Sr. VP (Age 66)
• Mr. James W. Tabak, Sr. VP of Admin. & Gov. Affairs (Age 62)
• Ms. Lori Mayer, VP of Investor Relations, Brand Management & Marketing Communications
• Mr. Michael Scott Sherman, Sr. VP, Gen. Counsel, Sec. & Assistant Treasurer (Age 52)
• Mr. Larry Baider, Sr. VP of People Strategy & Operations
• Dr. JoAnne Susan Reifsnyder R.N., Ph.D., Ph.D., ACHPN, MSN, MBA, RN, FAAN, Exec. VP of Clinical Operations & Chief Nursing Officer (Age 62)

Who are some of Genesis Healthcare's key competitors?

Some companies that are related to Genesis Healthcare include The Ensign Group (ENSG), National HealthCare (NHC), Five Star Senior Living (FVE), Diversicare Healthcare Services (DVCR) and Genesis Healthcare (GENN).
View all of GEN's competitors.

What other stocks do shareholders of Genesis Healthcare own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Genesis Healthcare investors own include Flaherty & Crumrine Preferred Securities Income Fund (FFC), Vaxart (VXRT), Gilead Sciences (GILD), Inovio Pharmaceuticals (INO), AT&T (T), Amarin (AMRN), Government Properties Income Trust (GOV), Advanced Micro Devices (AMD), Bausch Health Companies (BHC) and (CGC).

What is Genesis Healthcare's stock symbol?

Genesis Healthcare trades on the New York Stock Exchange (NYSE) under the ticker symbol "GEN."

How much money does Genesis Healthcare make?

Genesis Healthcare has a market capitalization of $0.00 and generates $4.57 billion in revenue each year.

How many employees does Genesis Healthcare have?

Genesis Healthcare employs 44,000 workers across the globe.

What is Genesis Healthcare's official website?

The official website for Genesis Healthcare is www.genesishcc.com.

Where are Genesis Healthcare's headquarters?

Genesis Healthcare is headquartered at 101 EAST STATE STREET, KENNETT SQUARE PA, 19348.

How can I contact Genesis Healthcare?

Genesis Healthcare's mailing address is 101 EAST STATE STREET, KENNETT SQUARE PA, 19348. The company can be reached via phone at 610-444-6350 or via email at [email protected].